Cleared Traditional

K971408 - SEVRAIN CRANIAL CLAMP (SCC-200 SERIES)

K971408 is an FDA 510(k) clearance for SEVRAIN CRANIAL CLAMP (SCC-200 SERIES), manufactured by Ikonos Corp.. The device is a Class 2 Neurology device with product code GXN cleared through the Traditional 510(k) pathway after a 391-day FDA review.

K971408 · Ikonos Corp. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1998
Decision
391d
Days
Class 2
Risk

K971408 is an FDA 510(k) clearance for the SEVRAIN CRANIAL CLAMP (SCC-200 SERIES). Classified as Plate, Cranioplasty, Preformed, Non-alterable (product code GXN), Class II - Special Controls.

Submitted by Ikonos Corp. (Portland, US). The FDA issued a Cleared decision on May 12, 1998 after a review of 391 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5330 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Ikonos Corp. devices

FDA 510(k) Submission Details - K971408

510(k) Number K971408 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 16, 1997
Decision Date May 12, 1998
Days to Decision 391 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
243d slower than avg
Panel avg: 148d · This submission: 391d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GXN Device Classification - Class 2, Special Controls

Product Code GXN Plate, Cranioplasty, Preformed, Non-alterable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5330
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.